Ng. Morgenthaler et al., APPLICATION OF A BIOASSAY WITH CHO CELLS FOR THE ROUTINE DETECTION OFSTIMULATING AND BLOCKING AUTOANTIBODIES TO THE TSH-RECEPTOR, Hormone and Metabolic Research, 30(3), 1998, pp. 162-168
The importance of bioassays measuring stimulating and blocking autoant
ibodies to the TSH-receptor (TSH-R) by their effect on CAMP production
in CHO cells transfected with the recombinant TSH-R is increasingly r
ecognized. The standard technique for this bioassay is cumbersome, as
it involves purification of serum IgG with polyethylene glycol (PEG) a
nd resuspension in hypotonic buffer. We have therefore established a s
impler approach for the detection of stimulating and blocking autoanti
bodies using JP09 CHO cells and unfractionated human serum. The cAMP c
oncentration was measured by a highly sensitive commercial radioimmuno
assay. Thyroid stimulating autoantibodies (TSAb) were present in 107
out of 126 patients with Graves' disease (85%) and in 4 out of 40 pati
ents with Hashimoto's thyroiditis (10%). Specificity was confirmed by
the fact that only 1 patient with insulin dependent diabetes mellitus
(IDDM) out of 64 patients with different non-thyroid autoimmune disord
ers (46 with IDDM, 10 with stiff man syndrome and 8 with rheumatoid ar
thrites) and 2 out of 100 healthy controls (2%) were positive in this
assay. In the subgroup of hyperthyroid Graves' disease patients 76 out
of 83 (92%) had TSAb and the same number had TSH binding inhibiting i
mmunoglobulin (TBII), as assessed by the commercial TRAK assay. Althou
gh both antibody types showed only a weak correlation (r = 0.30), a co
mbination of TSAb and TBII detected 98% of all Graves' patients and 99
% of the hyperthyroid subgroup. Thyroid blocking autoantibodies (TBAb)
were measured in 4 out of 24 TSAb negative patients with Graves' dise
ase (17%), who were hypothyroid and positive for TBII. A comparison of
our bioassay with the standard bioassay using PEG precipitation showe
d a good correlation (r = 0.76, p < 0.001), demonstrating the feasibil
ity of the simplified assay for the routine detection of TSAb and TBAb
in Graves' disease.